Our Clinical Trials
A Phase 3 Clinical Trial Comparing the Effectiveness of a New Investigational Treatment with Tirzepatide in Managing Type 2 Diabetes Glycaemic Control and Weight Reduction.
This study is being conducted at our Western Sydney and Canberra sites.
Apply NowThe study is examining if lowering Lipoprotein (a), a type of cholesterol, can reduce the risk of cardiovascular events. If you have known cardiovascular disease or are at risk of cardiovascular disease (including a family history), you might be eligible for this 4-year study. See below for more details.
This study is being conducted at our at our Western Sydney, Central Coast, Canberra, and Brisbane sites.
Apply NowA 51-week, placebo-controlled study evaluating the effectiveness of different dosages of a new investigational weight loss injectable treatment.
This study is being conducted at our Western Sydney, Central Coast and Brisbane sites.
Apply Now